Cellula BioPharma
Cellula BioPharma, located in Pearland, TX, is pioneering a revolutionary CAR-T platform technology specifically designed for the treatment of solid tumors. Their innovative approach addresses the significant unmet need in the field, as current CAR-T therapies have shown limited effectiveness against solid tumors despite advancements in hematologic malignancies.
The company has developed a unique Nucleotide Metabolic Reprogramed CAR (MRCA) that enhances the efficacy and safety of CAR-T cell therapy, validated through in vitro assays and various tumor mouse models. With a team of seasoned entrepreneurs, investigators, and physicians, Cellula BioPharma is positioned to overcome existing challenges in CAR-T therapy, particularly in promoting T cell persistence and combating immunosuppression in solid tumors.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.